Researchers sought to determine the 10-year risk for developing advanced neoplasia and assessed whether baseline colonoscopy findings were associated with long-term outcomes.
Expanded testing could increase detection of carriers for BRCA1/2, mutations in other predisposition genes.
Fecal immunochemical tests have proven to be an effective, noninvasive approach to detect later-stage colorectal cancer; however, questions remain regarding their ability to consistently identify early-stage cancers.
12.5 percent of those meeting USPSTF recommendations for low-dose CT had screening exam in past year.
No significant reductions found in 8-year breast cancer mortality for continuing vs stopping screening.
The US Multi-Society Task Force released updated recommendations for postcolonoscopy management strategies and polyp surveillance.
Monoferric will be supplied in 100mg/mL, 500mg/5mL, and 1000mg/10mL single-dose vials for intravenous infusion after dilution.
Medical and ethical considerations of fertility preservation in children with cancer are addressed in a clinical report from the American Academy of Pediatrics.
Odds of reporting cancer diagnosis increased for those with 10 or more lifetime sexual partners
Researchers concluded that bariatric surgery is strongly associated with an increased risk for colon cancer, though further research may be needed to establish an association between bariatric surgery and an increased risk for rectal cancer.
The ROW risk calculator makes its predictions based on age, comorbidities, functional status, tumor characteristics, and use of radiotherapy.
J Clin Med Res. 2019;11(4):247-255.
Quality of life in patients receiving netupitant/palonosetron chemotherapy induced nausea and vomiting.
Many breast cancer drugs approved in the United States may lack substantial clinical benefit, particularly in the palliative setting.
Researchers analyzed the association between baseline metabolic syndrome components and survival outcomes in women diagnosed with TNBC.
A review of the Pennsylvania Medical Marijuana Program defined the symptom profile of patients with breast cancer who sought to use medical marijuana.
More patients living with metastatic breast cancer reportedly would be willing to participate in clinical trials if some changes were made.
In the general population, BRCA1, BRCA2, PALB2, and ATM mutations were linked to a significant increased risk of breast cancer.
Estrogen alone and estrogen plus progestin appeared to have “opposite effects” on risk of breast cancer and death among postmenopausal women.
Deficits in use of sunscreen indicate that people pay little attention to the recommendations of health authorities, regardless of their skin type, and underscore an urgent need for targeted public information on its use.